Life Sciences Hub Wales Showcase Supporting the Life Sciences sector in Wales Rachel Russell Director Health and Value Team Pfizer UK PPGIPGBR3622 Why Wales Innovative ID: 761927
Download Presentation The PPT/PDF document "Life Sciences Hub Wales Showcase Suppor..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Life Sciences Hub Wales Showcase Supporting the Life Sciences sector in Wales
Rachel Russell Director Health and Value Team Pfizer UK
PP-GIP-GBR-3622 Why Wales?Innovative and collaborative approaches for a vibrant life sciences eco-system June 2018
PP-GIP-GBR-3622 A challenging environment which demands innovative and collaborative solutions between a variety of partners Challenging Environment Evolution of Delivery Achieved by Collaboration Long Term Conditions Increasing Costs Future Cuts Professional Shortage O utcomes Efficiency Q ua li ty Different Partners Different capabilities New Technology Real World Data Aging Population Smart Efficient SystemAs one of a number of Industry Leaders, it’s Pfizer responsibility to be part of the solution June 2018
PP-GIP-GBR-3622 June 2018 Through our Joint Working projects, Pfizer aims to work in partnership with a wide range of healthcare organisations to develop solutions that improve patient care and add value to the work of the NHS. •• Joint Working is defined as situations where the NHS and pharmaceutical companies work together for the benefit of patients with a shared commitment to successful delivery.The joint working between Swansea University and Pfizer Ltd is to focus on supporting the development of a system that better aligns industry, the NHS, and academia to innovating in the pursuit of improved patient and public outcomes.This first project within this collaboration will be the creation of a 3 year Clinical Digital Consultant (a Professor of Enhanced Health Innovation, Engagement and Outcomes) post to coordinate and lead projects.Benefits to patients include: improved early stage education and risk awareness of disease, improved activation, screening and detection of underlying conditions, & continual adaptation of pathways and patient interventions to balance outcome improvement with patient control over living a full and positive life with their condition.Benefits to Swansea include: creation of a concentrated network of clinicians, healthcare professionals, academics and local authorities, presenting opportunity to: –– Ensure a core digital infrastructure in which every interaction is captured, collected and utilized to drive continuous improvement in as near real-time a manner as possibleDevelop global leadership in value-based healthcare models, scalable to other systems in Wales, the UK and worldwide. •Benefits to Pfizer include: demonstrate that by working with novel partners to convey health information to hard to reach or high risk population groups we can activate a broader, earlier and more effective patient response, prove that Pfizer can partner with the healthcare system in the Swansea Bay City Region and employ novel technologies to help patients achieve real world outcomes from their medication equal to those achieved in a clinical trial setting, and enhance Pfizer’s reputation as a partner for healthcare innovation
Shared ambition to explore and develop innovative approaches to transforming patient health A global exemplar of value-based healthcare Swansea Bay integrated health system and life sciences & wellbeing village Pfizer clinical devel opment, health & value and digital innovation hub networks Transform how health and wellness is delivered, measured and managed PP-GIP-GBR-3622June 2018Scale innovation across Wales, the UK and to global marketsSwansea Health System PfizerAccelerate and facilitate new innovative initiatives‘Test-bed’ for transformative patient outcome and value-based health solutions
Mobile/self tracking Smart Home Analytics and Big data Wearables andbiosensors Care Coordination Telemedicine 3D Printing Virtual MedicalEdcationPP-GIP-GBR-3622June 2018The role of health technologies as part of the solution
Test locally, scale nationally, impact broadly Local (population 1m) Sub-National (3m) National (60m) Unique population access Llanelli Health & Life Sciences VillageAbertawe Bro Morgannwg & Hywel Dda Health Boards National Value-Based procurement co-creation Intent to shape globalCentre of Excellence in Value-Based HealthcareNovel Clinical CentresIntent for Transformative Sector Deal between UK Government & IndustryInclusive of future pricing agreement, currently under PPRS negotiationCohesive, consistent senior policy engagement PP-GIP-GBR-3622 June 2018